Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine) ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

Düsseldorf, Germany Wednesday, February 5, 2025, 18:00 Hrs [IST] ...

Algiax Pharmaceuticals, a clinical-stage biotech company focused on developing innovative treatments for chronic neuropathic pain, today announced compelling topline data from its Phase 2a clinical ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

Finance Minister Dominic LeBlanc says Canada will retaliate against Donald Trump’s tariffs despite the U.S. president’s ...

Allosteric GABAA-receptor modulator AP-325 showed rapid onset as well as long-lasting pain reduction in patients with chronic neuropathic pain in Phase 2a study Data confirm previously reported ...

The House of Lords voted in favour of increasing the maximum sentence for this crime from an unlimited fine to imprisonment.

Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know ...